Martek reaps regulatory omega-3 benefits
The whole DHA sector is gaining from a European Commission-approved statement regarding the omega-3 form and infant eye and brain health.
It is a welcome development for an industry that took a body blow when one of the first European Food Safety Authority (EFSA) article 14 children’s health claim opinions ruled against a similar claim submitted by Martek back in September, 2008.
Gray tells Shane Starling of that development and highlights other regulatory changes that have affected the sector.
